Uribe A, Alam M, Midtvedt T, Smedfors B, Theodorsson E
Dept. of Medicine, Karolinska Institute, Danderyd Hospital, Danderyd/Stockholm, Sweden.
Scand J Gastroenterol. 1997 Jul;32(7):691-9. doi: 10.3109/00365529708996520.
Previous studies suggest that E2 prostaglandins and the microflora may participate in the regulation of endocrine cells and of gastrointestinal cell kinetics. Our aim is to examine the actions of endogenous prostaglandins and of the microflora on gastrointestinal cell proliferation and tissue levels of neuroendocrine peptides.
Germfree and ex-germfree rats were treated with subcutaneous placebo or 1.5 mg/kg indomethacin for 3 days. All rats were labeled with 3H-methyl-thymidine, and biopsy specimens from different parts of the gastrointestinal tract were processed for autoradiography. DNA synthesis was estimated by the labeling index, except in the oxyntic mucosa, where the total number of labeled cells present in 7.5 mm mucosa was used. The concentration of neuroendocrine peptides was determined by radioimmunoassay.
In the germfree rat, indomethacin reduced DNA synthesis in the fundus, duodenum, and proximal jejunum (P < 0.05) and the number of villous cells throughout the small intestine (P < 0.05). Exposure to microflora increased DNA synthesis in the proximal and distal jejunum, ileum, and colon (P < 0.05 versus germfree controls) and the number of crypt cells in the distal small intestine and colon (P < 0.05) and reduced the number of villous cells in the small intestine (P < 0.05) but did not affect tissue concentrations of neuroendocrine peptides. Indomethacin increased the concentration of somatostatin in the stomach, duodenum, and colon of germfree rats (P < 0.001), the concentration of calcitonin gene-related peptide (CGRP) and enteroglucagon in the proximal and distal jejunum and ileum (P < 0.001), and the concentration of glucagon in the colon (P < 0.05). The concentrations of somatostatin, CGRP, and glucagon were lower in indomethacin-treated ex-germfree rats than in indomethacin-treated germfree rats (P < 0.01).
Indomethacin selectively reduced DNA synthesis in the upper gastrointestinal tract of germfree rats, indicating a basal stimulatory role for endogenous prostaglandins on cell proliferation. Endogenous prostaglandins modulate synthesis or release of gastrointestinal neuroendocrine peptides. Somatostatin may mediate indomethacin-induced reduction of DNA synthesis. The microflora stimulates cell proliferation and influences tissue levels of neuroendocrine peptides in a manner opposite to that of indomethacin.
先前的研究表明,E2前列腺素和微生物群可能参与内分泌细胞及胃肠细胞动力学的调节。我们的目的是研究内源性前列腺素和微生物群对胃肠细胞增殖及神经内分泌肽组织水平的作用。
将无菌大鼠和悉生后无菌大鼠皮下注射安慰剂或1.5mg/kg消炎痛,持续3天。所有大鼠均用3H-甲基胸腺嘧啶核苷标记,对胃肠道不同部位的活检标本进行放射自显影处理。除胃黏膜外,通过标记指数评估DNA合成,胃黏膜则采用7.5mm黏膜中标记细胞的总数。通过放射免疫分析法测定神经内分泌肽的浓度。
在无菌大鼠中,消炎痛降低了胃底、十二指肠和空肠近端的DNA合成(P<0.05)以及整个小肠绒毛细胞的数量(P<0.05)。接触微生物群增加了空肠近端和远端、回肠和结肠的DNA合成(与无菌对照相比,P<0.05)以及远端小肠和结肠隐窝细胞的数量(P<0.05),并减少了小肠绒毛细胞的数量(P<0.05),但不影响神经内分泌肽的组织浓度。消炎痛增加了无菌大鼠胃、十二指肠和结肠中生长抑素的浓度(P<0.001),空肠近端和远端以及回肠中降钙素基因相关肽(CGRP)和肠高血糖素的浓度(P<0.001),以及结肠中胰高血糖素的浓度(P<0.05)。消炎痛处理的悉生后无菌大鼠中生长抑素、CGRP和胰高血糖素的浓度低于消炎痛处理的无菌大鼠(P<0.01)。
消炎痛选择性降低无菌大鼠上消化道的DNA合成,表明内源性前列腺素对细胞增殖具有基础刺激作用。内源性前列腺素调节胃肠神经内分泌肽的合成或释放。生长抑素可能介导消炎痛诱导的DNA合成减少。微生物群以与消炎痛相反的方式刺激细胞增殖并影响神经内分泌肽的组织水平。